Media Resources

2019

Health Action International Comments on WHO Decision on Long-acting Analogue Insulin

Breaking Down Barriers to Accessing Internationally Controlled Essential Medicines Key to Ending Pain and Suffering of Millions

Snakebite Incidents, Response, & Antivenom Supply (Uganda)

Snakebite Incidents, Response, & Antivenom Supply (Kilifi County, Kenya)

HAI Snakebite Project in Sub-Saharan Africa

Policy Brief- WHA 72- The need for Global Action to Reduce Snakebite Death and Disability

Statement to WHA72 on Access to Medicines and Vaccines

Statement to WHA72 on the Global Challenge of Antimicrobial Resistance

Governments who Support Transparency Must Raise Their Voices at the World Health Assembly

HAI Applauds JURI Decision to Keep SPC Assessment on European Parliament Agenda

2018

Dutch Government Not Living up to Promises to Make New Medicines Affordable

Snakebite Incidents, Response & Antivenom Supply (Uganda)

Civil Society Position on European Commission Proposal for the Introduction of an SPC Manufacturing Waiver

Regulating Off-label Use of Medicines in Europe

Global Coalition of Health Organisations Announces First-ever International Snakebite Awareness Day

Statement on ENVI Committee Report on Health Technology Assessments

Statement to WHO on Roadmap Report on Access to Medicines & Vaccines

Prices and Availability of Locally Produced and Imported Medicines in Kenya

Snakebite Incidents, Response & Antivenom Supply in Kilifi County, Kenya

HAI Snakebite Programme – Sub-Saharan Africa

HAI Snakebite Programme – Kenya

HAI Snakebite Programme – Zambia

Guide to HAI’s 2018 European Union Projects

2017 Annual Report: Tackling Health Inequalities through Treatment Access

Ensuring EU Funded Medical R&I Delivers for EU Citizens and Beyond

Health Action International Hails Adoption of Milestone Resolution on Snakebite Envenoming at 71st World Health Assembly

Statement to WHA71 on Addressing the Global Shortage of, and Access to, Medicines and Vaccines

Statement to the Seventy-first World Health Assembly on GPW13

Policy Brief: The Way Forward for Access to Medicines

International Panel Puts Intellectual Property Incentives Framework Under Microscope as Prices of New Medicines Rise in Europe